Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001033427-10-000002
Filing Date
2010-01-11
Accepted
2010-01-11 11:44:59
Documents
2
Group Members
COLE PARTNERS LLCDAVID L. COHENHAROLD J. LEVYIRIDIAN ASSET MANAGEMENT LLCIRIDIAN CHARTER FUND, L.P.IRIDIAN PARTNERS FUND, LPIRIDIAN PRIVATE BUSINESS VALUE EQUITY FUND, L.P.RENOMA PARTNERS LLC

Document Format Files

Seq Description Document Type Size
1 enzonpharm13da1081909.txt SC 13D/A 33560
2 powerattorneycohenlevy.txt EX-24 4707
  Complete submission text file 0001033427-10-000002.txt   41005
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Subject) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-35587 | Film No.: 10519456
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 276 POST ROAD WEST WESTPORT CT 06880-4704
Business Address 276 POST RD WEST WESTPORT CT 06880-4704 2033417800
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by) CIK: 0001033427 (see all company filings)

EIN.: 061439577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A